Loading clinical trials...
Loading clinical trials...
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study conducted in the United States (US) to assess the efficacy of RP-G28 compared to placebo on symptom reduction ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Ritter Pharmaceuticals, Inc.
NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more
NCT06177938 · Lactose Intolerance
NCT06773650 · Lactose Intolerant, Lactose Malabsorption, and more
NCT07494123 · Prematurity, Lactose Intolerance, and more
NCT05658861 · Lactose Intolerance, Adult Type
Research Facility
Birmingham, Alabama
Research Site
Chula Vista, California
Research Site
Huntington Park, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions